Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) Guideline for CYP2D6 Genotype and Use of 5‐ <scp> HT 3 </scp> Receptor Antagonists: 2026 Update

Claire Moore, Melissa S. Bourque, Andreas Halman, José A. G. Agúndez, Cynthia A. Prows, Keiko Hikino, Matthias Schwab, Carolyn J. Oxencis, Dharmisha Chauhan, Meta H.M. Diekstra, Susie E. Long, Gillian C. Bell, Andrea Gaedigk, Michelle Whirl‐Carrillo, Teri E. Klein, Kelly E. Caudle, Rachel Conyers

Open source

DOI: 10.1002/cpt.70291
Published: 2026-04-14
Container: Clinical Pharmacology & Therapeutics
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70291,
  title = {Clinical Pharmacogenetics Implementation Consortium (
                    <scp>CPIC</scp>
                    ) Guideline for
                    <i>CYP2D6</i>
                    Genotype and Use of 5‐
                    <scp>
                      HT
                      <sub>3</sub>
                    </scp>
                    Receptor Antagonists: 2026 Update},
  author = {Claire Moore and Melissa S. Bourque and Andreas Halman and José A. G. Agúndez and Cynthia A. Prows and Keiko Hikino and Matthias Schwab and Carolyn J. Oxencis and Dharmisha Chauhan and Meta H.M. Diekstra and Susie E. Long and Gillian C. Bell and Andrea Gaedigk and Michelle Whirl‐Carrillo and Teri E. Klein and Kelly E. Caudle and Rachel Conyers},
  year = {2026},
  journal = {Clinical Pharmacology \&amp; Therapeutics},
  doi = {10.1002/cpt.70291},
  url = {https://doi.org/10.1002/cpt.70291}
}

RIS

TY  - JOUR
TI  - Clinical Pharmacogenetics Implementation Consortium (
                    <scp>CPIC</scp>
                    ) Guideline for
                    <i>CYP2D6</i>
                    Genotype and Use of 5‐
                    <scp>
                      HT
                      <sub>3</sub>
                    </scp>
                    Receptor Antagonists: 2026 Update
AU  - Claire Moore
AU  - Melissa S. Bourque
AU  - Andreas Halman
AU  - José A. G. Agúndez
AU  - Cynthia A. Prows
AU  - Keiko Hikino
AU  - Matthias Schwab
AU  - Carolyn J. Oxencis
AU  - Dharmisha Chauhan
AU  - Meta H.M. Diekstra
AU  - Susie E. Long
AU  - Gillian C. Bell
AU  - Andrea Gaedigk
AU  - Michelle Whirl‐Carrillo
AU  - Teri E. Klein
AU  - Kelly E. Caudle
AU  - Rachel Conyers
PY  - 2026
JO  - Clinical Pharmacology &amp; Therapeutics
DO  - 10.1002/cpt.70291
UR  - https://doi.org/10.1002/cpt.70291
ER  -

APA

Moore, C., Bourque, M. S., Halman, A., Agúndez, J. A. G., Prows, C. A., Hikino, K., Schwab, M., Oxencis, C. J., Chauhan, D., Diekstra, M. H., Long, S. E., Bell, G. C., Gaedigk, A., Whirl‐Carrillo, M., Klein, T. E., Caudle, K. E., & Conyers, R. (2026). Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) Guideline for CYP2D6 Genotype and Use of 5‐ <scp> HT 3 </scp> Receptor Antagonists: 2026 Update. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70291

Source records

crossref · retrieved 2026-09-26T12:42:31.210Z

Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) Guideline for <i>CYP2D6</i> Genotype and Use of 5‐ <scp> HT <sub>3</sub> </scp> Receptor Antagonists: 2026 Update

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records